Proto Labs, Inc. — Q3 2022 Form 10-Q
Reporting period: Three and nine months ended September 30, 2022. Proto Labs provides digital manufacturing of custom parts through injection molding, CNC machining, 3D printing and sheet metal, alongside the Hubs network of manufacturing partners. Financial amounts below are in U.S. dollars.
Financial performance
| Metric | Q3 2022 | Q3 2021 | Nine months 2022 | Nine months 2021 |
|---|---|---|---|---|
| Revenue | $121.7 million | $125.3 million | $372.8 million | $364.5 million |
| Gross profit / margin | $53.6 million / 44.1% | $55.3 million / 44.1% | $166.9 million / 44.8% | $167.3 million / 45.9% |
| Operating income / margin | $6.1 million / 5.0% | $6.9 million / 5.5% | $19.1 million / 5.2% | $27.3 million / 7.5% |
| Net income | $4.0 million | $4.8 million | $11.6 million | $21.5 million |
| Diluted EPS | $0.14 | $0.17 | $0.42 | $0.77 |
| Operating cash flow | Not stated for quarter | Not stated for quarter | $51.6 million | $32.2 million |
At September 30, cash and cash equivalents were $59.4 million and marketable securities were $54.5 million, for $113.9 million in combined cash and securities. Current assets were $192.4 million versus current liabilities of $60.7 million. The filing reports no conventional borrowings; disclosed financing obligations are primarily lease liabilities, with $1.5 million current finance lease liabilities and none long-term. Total liabilities were $96.1 million.
Changes versus comparable periods
- Q3 revenue declined 2.9%; nine-month revenue rose 2.3%. Q3 customer count increased 1.5% to 23,816; nine-month customer count increased 2.4% to 47,793.
- Injection Molding revenue fell 15.2% in Q3 and 9.6% year to date. CNC Machining grew 8.8% and 16.3%, respectively; 3D Printing grew 6.6% and 10.1%.
- Nine-month gross margin fell 1.1 percentage points, which management attributed mainly to materials-cost inflation and revenue mix. Q3 gross margin was unchanged year over year.
- Nine-month operating income declined 29.8% and net income declined 45.9%. The period included $6.4 million of Japan closure costs; the prior-year period included an $8.5 million favorable change in Hubs contingent consideration fair value.
- Foreign exchange movements, particularly weaker sterling and the euro against the U.S. dollar, reduced revenue by $4.1 million in Q3 and $8.4 million for the first nine months. Accumulated other comprehensive loss increased to $47.0 million, largely reflecting currency translation losses.
Cash flow, unusual items and outlook
- Nine-month operating cash flow was $51.6 million. Investing used $43.4 million, including $30.2 million of net marketable-security purchases and $13.2 million of net capital asset purchases; financing used $12.8 million, including $13.1 million of share repurchases. Cash declined $6.6 million from year-end 2021.
- The company plans to close its Japan manufacturing facility and exit the market, expecting substantial completion within the next year. Nine-month charges included $2.3 million severance, $2.3 million fixed-asset write-downs, $0.9 million facility costs, $0.6 million goodwill impairment and $0.3 million other charges. Japan revenue fell 57.9% in Q3.
- Sale of a Maple Plain facility generated $3.2 million net proceeds and a $1.2 million gain recorded in general and administrative expense.
- Management expects cost of revenue and personnel-related costs to rise in absolute terms, and anticipates continued investment in technology and personnel, with future operating expenses expected to increase. No quantified earnings or revenue guidance is provided in the filing.
- Risks and sensitivities noted include foreign-exchange exposure, materials and logistics inflation, and tax losses in jurisdictions where valuation allowances prevent tax benefits. The company does not hedge currency exposure; it says a hypothetical 10% adverse exchange-rate change could materially affect operating results. Risk factors were reported as unchanged from the 2021 Form 10-K. Management stated disclosure controls were effective; it reported no litigation expected to have a material adverse effect.
Important facts for investors to verify
- Whether the Japan exit proceeds on schedule and whether further closure charges or asset-sale proceeds arise.
- Whether Injection Molding weakness, materials inflation and currency impacts persist, and how product and geographic mix affect margins.
- Whether cash generation remains strong after capital spending, securities purchases and share repurchases; $48.8 million remained authorized under the repurchase program at quarter-end.
- How foreign-exchange movements, investment-security unrealized losses and the elevated year-to-date effective tax rate affect reported earnings and equity.